Pharmacists authorized to prescribe, dispense, and administer drugs to prevent acquisition of human immunodeficiency virus; pharmacists authorized to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent acquisition of human immunodeficiency virus.
Impact
HF2466 will implement changes in the state law concerning healthcare and pharmacy practices. It allows pharmacists to order, conduct, and interpret laboratory tests required for the therapies related to HIV prevention. By extending these responsibilities to pharmacists, the intent is to reduce barriers to obtaining essential medications, possibly leading to better health outcomes for populations at risk of HIV. The bill also proposes a standardized protocol for pharmacists, ensuring that they are adequately trained and supported in their roles.
Summary
House File 2466 aims to enhance the role of pharmacists in the prevention of HIV by authorizing them to prescribe and administer antiretroviral drugs. The bill emphasizes comprehensive coverage for these medications, mandating that health plans cannot impose step therapy protocols that would limit a patient's access to necessary treatments. The approach is designed to facilitate a more accessible healthcare framework for individuals at risk of HIV, promoting preventative measures such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
Contention
While the bill has garnered support from various public health advocates who view it as a step forward in combating HIV, it may face contention from within the healthcare community regarding the scope of pharmacist authority. Concerns have been raised about the potential for overstepping the traditional roles of pharmacists, leading to debates about patient safety and the adequacy of the proposed training for pharmacists. Opponents fear that the bill might allow pharmacists to operate in a space traditionally held by physicians, possibly leading to complications in patient management.
Licensed pharmacist authority expanded to initiate, order, and administer vaccines and medical and laboratory tests; and medical assistance coverage required.
Licensed pharmacists authority to initiate, order and administer vaccines and certain medical and laboratory tests; coverage under medical assistance requirement
Pharmacists authorized to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use, or treatment of COVID-19.
Certain formulary changes during the plan year prohibition provision and medical assistance program formulary changes implementation for certain enrollees prohibition provision
Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19